Author： Scott L.J. Lamb H.M.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.58, Iss.2, 1999-08, pp. : 305-311
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Palivizumab: A Viewpoint by Siva Subramanian
Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. :
Access to resources
Recommend
Palivizumab poor performer for prevention of RSV
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. :
Palivizumab pharmacy programme cost saving in the US
Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. :
Palivizumab prophylaxis safe for second RSV season
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :
Palivizumab for RSV prevention in high-risk children
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :